Nanocarriers in The Treatment of Head and Neck Cancer-Reference-Cited by-同舟云学术

Nanocarriers in The Treatment of Head and Neck Cancer

Published:2023-03-05 Issue: Volume: Page:255-279
ISSN:
Container-title:Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
language:
Short-container-title:

Author:

Garg Ashish¹,Gawali Vaibhav Kumar S.²,Gautam Rupesh K.³,Singla Rajeev K.⁴,Ashique Sumel⁵

Affiliation:

1. Rani Durgavati University,Department of P. G. Studies and Research in Chemistry and Pharmacy,,Jabalpur,India,482001,

2. University of Cincinnati,Department of Internal Medicine/Nephrology,Cincinnati,United States,

3. Maharishi Markandeshwar University,Department of Pharmacology,Ambala,India,134007,

4. West China Hospital, Sichuan University,Sichuan,China,610041,|Global Research and Publishing Foundation,New Delhi,India,

5. Bharat Institute of Technology (BIT),Department of Pharmaceutics,Meerut,India,

Abstract

Nowadays, Head and neck cancer is treated as a major disease worldwide. Several types of treatments are involved in this type of cancer, including immunotherapy, chemotherapy, radiation therapy, and surgery. Considering the clinical results from the past decades, these types of treatments resulted in no significant improvement in survival rates. To overcome these issues, versatile nanoparticles targeting selective tumors are considered. The targeted therapeutics based on the nanoparticle has a wide range of applications, such as photothermal therapy, radiosensitization, chemotherapeutic drug delivery, and gene splicing. In this study, we have discussed the recent advancement in targeted therapeutics based on nanoparticles for head and neck cancer. Further, we have described the targets in Head and Neck cancer and, thus, shared future perspectives.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference119 articles.

1. Parkin D.M.; Bray F.; Ferlay J.; Pisani P.; Global cancer statistics, 2002. CA Cancer J Clin 2005,55(2),74-108

2. Ferlay J.; Shin H.R.; Bray F.; Forman D.; Mathers C.; Parkin D.M.; Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,127(12),2893-2917

3. Blot W.J.; McLaughlin J.K.; Winn D.M.; Austin D.F.; Greenberg R.S.; Preston-Martin S.; Bernstein L.; Schoenberg J.B.; Stemhagen A.; Fraumeni J.F.; Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988,48(11),3282-3287

4. Hashibe M.; Brennan P.; Benhamou S.; Castellsague X.; Chen C.; Curado M.P.; Maso L.D.; Daudt A.W.; Fabianova E.; Wunsch-Filho V.; Franceschi S.; Hayes R.B.; Herrero R.; Koifman S.; La Vecchia C.; Lazarus P.; Levi F.; Mates D.; Matos E.; Menezes A.; Muscat J.; Eluf-Neto J.; Olshan A.F.; Rudnai P.; Schwartz S.M.; Smith E.; Sturgis E.M.; Szeszenia-Dabrowska N.; Talamini R.; Wei Q.; Winn D.M.; Zaridze D.; Zatonski W.; Zhang Z-F.; Berthiller J.; Boffetta P.; Boffetta P.; Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007,99(10),777-789

5. D’Souza G.; Kreimer A.R.; Viscidi R.; Pawlita M.; Fakhry C.; Koch W.M.; Westra W.H.; Gillison M.L.; Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007,356(19),1944-1956